Showing results (2271-2280 of 2,927) with videos related to
Sort By:
Pageof 293
Plos One|October 15, 2013
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individualsHenrik N Kløverpris, Akil Jackson, Amanda Handley, et al.The Journal of Clinical Investigation|May 1, 1990
Human seminal clusterin (SP-40,40). Isolation and characterizationM K O'Bryan, H W Baker, J R Saunders, et al.The Journal of Infectious Diseases|March 9, 2016
Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02Ellen M Leitman, Jacob Hurst, Masahiko Mori, et al.Cell Reports|January 10, 2019
A Persistence Detector for Metabolic Network Rewiring in an AnimalJote T Bulcha, Gabrielle E Giese, Md Zulfikar Ali, et al.ACS Applied Bio Materials|January 8, 2022
Using Aldehyde Synergism To Direct the Design of Degradable Pro-Antimicrobial NetworksDahlia N Amato, Douglas V Amato, Yetunde Adewunmi, et al.Journal of Neurosurgery|June 1, 1976
Evaluation of mithramycin in the treatment of anaplastic gliomasM D Walker, E Alexander, W E Hunt, et al.Organic Letters|August 19, 2020
Total Synthesis of Kalimantacin AJonathan A Davies, Freya M Bull, Paul D Walker, et al.Nature|October 12, 2000
Immune control of HIV-1 after early treatment of acute infectionE S Rosenberg, M Altfeld, S H Poon, et al.Plos One|April 6, 2012
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Chanson J Brumme, Michael M Lederman, et al.AIDS Research and Human Retroviruses|September 10, 2013
HIV subtype influences HLA-B*07:02-associated HIV disease outcomeHenrik N Kløverpris, Emily Adland, Madoka Koyanagi, et al.Pageof 293